Pharmacy Report Archives - Page 3 of 152 - Becker's Hospital Review

5 systems' plan for a breakthrough cancer drug | Is medication safety improving? | OIG questions $587.7M in Medicare drug payments | 10 systems hiring pharmacy leaders | FDA expands Mounjaro approval

Plus: The states where hospitals are competing hardest for growth in 2026 September 3, 2026 1. Is medication safety actually improving? Full story 2. 5 systems to fast-track breakthrough pancreatic cancer drug Full story 3. Spend three days with the…

12 new drugs in shortage | 13 weight-loss drugs in the pipeline | FDA wins in tirzepatide shortage fight | 2 drug recalls to know | Drug supplier cyberattack affects oncology

Plus: 381 cleanest hospitals September 2, 2026 1. 12 new drugs in shortage Full story 2. 13 weight-loss drugs in the pipeline: What’s ahead for each Full story 3. Build or buy is the wrong first question for pharmacy AI.…

Trump strikes pricing deals with 9 drugmakers | 5 340B court updates | Novartis halts CAR-T trials after 3 deaths | Semaglutide dropout rate hits 49% | Ohio system names regional CPO

Plus: FDA OKs 1st-of-its-kind drug for rare blood disorder September 1, 2026 1. Trump administration strikes pricing deals with 9 more drugmakers Full story 2. 5 340B court updates to know Full story 3. How much specialty pharmacy revenue slips…

The pharmacy failures behind Ascension's drug mix-up | 5th hospital sues CVS over 340B | Employers' GLP-1 cost strategy: 6 notes | Fla. sues 2 PBMs | Walmart to pay $50M in opioid prescriptions settlement

Plus: FDA OKs 1st oral drug for rare autoimmune disease August 31, 2026 1. Milwaukee hospital sues CVS over $18M in alleged 340B diversion Full story 2. Inside the pharmacy failures behind Ascension hospital’s drug mix-up that harmed 4 patients…

Critical drug shortage triggers FDA import plan | Ascension drug mix-up sparks medical error debate | AHA to CMS: Learn from 340B history | Court upholds Medicare drug price negotiations | 10 systems seeking pharmacy leaders

Plus: Medicare’s GLP-1 program gains traction at major pharmacies August 27, 2026 1. Ifosfamide shortage turns ‘critical,’ FDA to allow overseas imports Full story 2. Ascension drug mix-up renews focus on medical error criminalization Full story 3. More than 500 pharmacy…

FDA approves 1st-of-its-kind pancreatic cancer drug | The 340B changes AHA, AAMC want | Thyroid drug recalled | Family speaks after Ascension pharmacy error | 3 GI cancer sites get new treatment

Plus: CMS invests $3.15M in Ohio pharmacy infrastructure August 26, 2026 1. FDA approves pancreatic cancer drug that nearly doubles survival time Full story 2. 5 provisions AAMC, AHA want rewritten in parallel 340B pushes Full story 3. Spend three days…

10 drug categories facing the most shortages | States reject Trump's Medicaid GLP-1 deal | 6 new FDA-approved drugs | GLP-1s and breast cancer: 5 notes | Canada imposes 50% retaliatory tariffs

Plus: 25 best metro areas for healthcare access August 25, 2026 1. States reject Trump’s discounted Medicaid GLP-1 deal Full story 2. 10 drug categories with the most active shortages Full story 3. Duke and UChicago Medicine are deciding what…

Ascension hospital says pharmacy error harmed 4 patients | Cost Plus tackles pediatric cancer drug costs | FDA halts Regenxbio trial | Inside Lilly and Novo's GLP-1 copycat fight | 39K+ eye drop bottles recalled

Plus: Novo tests lower-dose Wegovy August 24, 2026 1. Ascension hospital confirms pharmacy medication error harmed 4 patients Full story 2. Cost Plus Drugs partners to reduce cost of pediatric cancer trial meds Full story 3. Drug pricing pressure, 340B uncertainty,…

11 clinics decertified in 340B ruling | 12-hospital system saves millions with inventory shift | FDA OKs 1st rare disease treatment | Wis. hospital 1st to deliver novel hearing loss therapy | 10 systems hiring pharmacy leaders

Plus: 6 takeaways for hospitals as US debt tops $40 trillion August 20, 2026 1. Court sides with drugmakers in 340B dispute, decertifies 11 clinics Full story 2. How a 12-hospital system saved millions with an inventory overhaul Full story…

Safety event harms 4 patients: Ascension hospital CEO | Trump nominates FDA chief | PBMs to post TrumpRx price comparisons | 7 systems expanding pharmacy services | What attracts Gen Z to leadership roles

Plus: mRNA melanoma vaccine succeeds in phase 3 trial August 19, 2026 1. Ascension hospital CEO apologizes for safety event that harmed 4 patients Full story 2. ‘No-brainer’: PBMs commit to posting TrumpRx price comparisons Full story 3. Pharmacy is…